PMID: 44887Dec 1, 1979

Further observations on a low-molecular-weight natriuretic substance in the urine of normal man

Kidney International
E M ClarksonH E de Wardener

Abstract

Large quantities of the low-molecular-weight natriuretic material (F4), which appears after the salts when fractionated on G-25 Sephadex column, were obtained from the urine of normal man on a normal diet. The natriuretic substance in F4 was (1) untrafiltrable through a membrane with a claimed molecular-weight cut-off of 500 daltons (Amicon UMO5); (2) soluble in more polar organic solvents; (3) totally soluble in 95% acetone when specific activity was doubled; (4) relatively resistant to heating at 100 degrees C for 1 hour at a pH of 10, and to heating at 110 degrees C in 6 N hydrochloric acid for up to 90 hours under anaerobic conditions, and treatment with nitrous acid; it was less resistant to these procedures when extracted into 95% acetone; (5) not destroyed by trypsin, chymotrypsin, pronase, pepsin, leucine aminopeptidase, and subtilysin, nor was it destroyed by pepsin, leucine aminopeptidase, subtilysin, carboxypeptidase A and B, and aminopeptidase M, or by monoamine oxidase, aryl sulphatase, and beta-glucuronidase when extracted into 95% acetone. The natriuretic substance in the 95% acetone-soluble F4 was totally destroyed by incubation with prolidase. The least amount of 95% acetone-soluble F4 required to produce a sig...Continue Reading

References

Mar 1, 1984·Pflügers Archiv : European journal of physiology·B Martin, H Favre
Jan 1, 1989·Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology·G Castañeda-Hernández
Jan 2, 1987·European Journal of Biochemistry·M CrabosJ F Cloix
Jan 15, 1993·European Journal of Biochemistry·M TamuraT Inagami
Nov 1, 1982·Clinical and Experimental Pharmacology & Physiology·T Morgan, C Ray
Aug 29, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·J O AdebayoA U Krettli
Feb 11, 2014·Clinica Chimica Acta; International Journal of Clinical Chemistry·Silvia BaecherMichael Vogeser
Jun 20, 1981·British Medical Journal
Jan 1, 1986·Critical Reviews in Clinical Laboratory Sciences·S W Graves
Jan 1, 1985·Clinical and Experimental Hypertension. Part A, Theory and Practice·E M Clarkson, H E de Wardener
Jun 1, 1982·Kidney International
Jan 1, 1984·Experimental Eye Research·P F NicholsB Becker
Jun 1, 1984·Australian and New Zealand Journal of Medicine·R B SewellS P Wilkinson
Jan 1, 1983·Acta Paediatrica Scandinavica. Supplement·A E Persson
Jul 1, 1994·European Journal of Clinical Investigation·R H StraubJ Schölmerich
Jan 1, 1989·The Korean Journal of Internal Medicine·Y S YoonH R Moon
Sep 26, 2008·The Journal of Pharmacology and Experimental Therapeutics·Laddawan SenggunpraiYasushi Yamazoe
May 1, 1982·Annals of Clinical Biochemistry·H E de Wardener

Citations

Nov 1, 1975·The Journal of Clinical Investigation·H FavreJ J Bourgoignie
Jul 1, 1972·Kidney International·P R BrownH E de Wardener
Jun 1, 1972·The Journal of Clinical Investigation·J J BourgoignieN S Bricker

Related Concepts

Carboxypeptidase A
Urine
Chromatography
Leucine Aminopeptidase
Monoamine Oxidase [PK]
X-Pro dipeptidase
Beta-glucuronidase
Acetone Measurement
Carboxypeptidase A Activity
Monoamine Oxidase

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.